Literature DB >> 30082491

Integrative 3' Untranslated Region-Based Model to Identify Patients with Low Risk of Axillary Lymph Node Metastasis in Operable Triple-Negative Breast Cancer.

Lei Wang1,2,3, Xin Hu4,2,3, Peng Wang5, Zhi-Ming Shao4,2,3,6.   

Abstract

BACKGROUND: Sentinel lymph node biopsy is the standard surgical staging approach for operable triple-negative breast cancer (TNBC) with clinically negative axillae. In this study, we sought to develop a model to predict TNBC patients with negative nodal involvement, who would benefit from the exemption of the axillary staging surgery.
MATERIALS AND METHODS: We evaluated 3' untranslated region (3'UTR) profiles using microarray data of TNBC from two Gene Expression Omnibus datasets. Samples from GSE31519 were divided into training set (n = 164) and validation set (n = 163), and GSE76275 was used to construct testing set (n = 164). We built a six-member 3'UTR panel (ADD2, COL1A1, APOL2, IL21R, PKP2, and EIF4G3) using an elastic net model to estimate the risk of lymph node metastasis (LNM). Receiver operating characteristic and logistic analyses were used to assess the association between the panel and LNM status.
RESULTS: The six-member 3'UTR-panel showed a high distinguishing power with an area under the curve of 0.712, 0.729, and 0.708 in the training, validation, and testing sets, respectively. After adjustment by tumor size, the 3'UTR panel retained significant predictive power in the training, validation, and testing sets (odds ratio = 4.93, 4.58, and 3.59, respectively; p < .05 for all). A combinatorial analysis of the 3'UTR panel and tumor size yielded an accuracy of 97.2%, 100%, and 100% in training, validation, and testing set, respectively.
CONCLUSION: This study established an integrative 3'UTR-based model as a promising predictor for nodal negativity in operable TNBC. Although a prospective study is needed to validate the model, our results may permit a no axillary surgery option for selected patients. IMPLICATIONS FOR PRACTICE: Currently, sentinel lymph node biopsy is the standard approach for surgical staging in breast cancer patients with negative axillae. Prediction estimation for lymph node metastasis of breast cancer relies on clinicopathological characteristics, which is unreliable, especially in triple-negative breast cancer (TNBC)-a highly heterogeneous disease. The authors developed and validated an effective prediction model for the lymph node status of patients with TNBC, which integrates 3'UTR markers and tumor size. This is the first 3'UTR-based model that will help identify TNBC patients with low risk of nodal involvement who are most likely to benefit from exemption axillary surgery. © AlphaMed Press 2018.

Entities:  

Keywords:  3′ untranslated region; Alternative polyadenylation; Lymph node; Prediction modeling; Triple‐negative breast cancer

Year:  2018        PMID: 30082491      PMCID: PMC6324632          DOI: 10.1634/theoncologist.2017-0609

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  42 in total

Review 1.  Triple-negative breast cancer.

Authors:  William D Foulkes; Ian E Smith; Jorge S Reis-Filho
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

Review 2.  Alternative cleavage and polyadenylation: extent, regulation and function.

Authors:  Ran Elkon; Alejandro P Ugalde; Reuven Agami
Journal:  Nat Rev Genet       Date:  2013-07       Impact factor: 53.242

3.  Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.

Authors:  Carl-Magnus Rudenstam; David Zahrieh; John F Forbes; Diana Crivellari; Stig B Holmberg; Piercarlo Rey; David Dent; Ian Campbell; Jürg Bernhard; Karen N Price; Monica Castiglione-Gertsch; Aron Goldhirsch; Richard D Gelber; Alan S Coates
Journal:  J Clin Oncol       Date:  2005-12-12       Impact factor: 44.544

4.  Alternative cleavage and polyadenylation during colorectal cancer development.

Authors:  Adam R Morris; Arnold Bos; Begoña Diosdado; Koos Rooijers; Ran Elkon; Anne S Bolijn; Beatriz Carvalho; Gerrit A Meijer; Reuven Agami
Journal:  Clin Cancer Res       Date:  2012-08-08       Impact factor: 12.531

5.  Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing.

Authors:  Yonggui Fu; Yu Sun; Yuxin Li; Jie Li; Xingqiang Rao; Chong Chen; Anlong Xu
Journal:  Genome Res       Date:  2011-04-07       Impact factor: 9.043

6.  Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.

Authors:  Roland Seiler; Lucia L Lam; Nicholas Erho; Mandeep Takhar; Anirban P Mitra; Christine Buerki; Elai Davicioni; Eila C Skinner; Siamak Daneshmand; Peter C Black
Journal:  J Urol       Date:  2016-04-19       Impact factor: 7.450

7.  Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types.

Authors:  Zheng Xia; Lawrence A Donehower; Thomas A Cooper; Joel R Neilson; David A Wheeler; Eric J Wagner; Wei Li
Journal:  Nat Commun       Date:  2014-11-20       Impact factor: 14.919

8.  Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Armando E Giuliano; James L Connolly; Stephen B Edge; Elizabeth A Mittendorf; Hope S Rugo; Lawrence J Solin; Donald L Weaver; David J Winchester; Gabriel N Hortobagyi
Journal:  CA Cancer J Clin       Date:  2017-03-14       Impact factor: 508.702

9.  Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation.

Authors:  Wayne O Miles; Antonio Lembo; Angela Volorio; Elena Brachtel; Bin Tian; Dennis Sgroi; Paolo Provero; Nicholas Dyson
Journal:  Cancer Res       Date:  2016-10-10       Impact factor: 12.701

10.  Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.

Authors:  Takaaki Fujii; Reina Yajima; Hironori Tatsuki; Hiroyuki Kuwano
Journal:  Anticancer Res       Date:  2016-04       Impact factor: 2.480

View more
  5 in total

1.  Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer.

Authors:  Yi Yao; Yuxin Chu; Bin Xu; Qinyong Hu; Qibin Song
Journal:  Cancer Med       Date:  2019-01-10       Impact factor: 4.452

Review 2.  Alternative polyadenylation: methods, mechanism, function, and role in cancer.

Authors:  Yi Zhang; Lian Liu; Qiongzi Qiu; Qing Zhou; Jinwang Ding; Yan Lu; Pengyuan Liu
Journal:  J Exp Clin Cancer Res       Date:  2021-02-01

Review 3.  Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.

Authors:  Minru Liao; Rui Qin; Wei Huang; Hong-Ping Zhu; Fu Peng; Bo Han; Bo Liu
Journal:  J Hematol Oncol       Date:  2022-04-12       Impact factor: 17.388

4.  Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.

Authors:  Lei Wang; Guan-Tian Lang; Meng-Zhu Xue; Liu Yang; Li Chen; Ling Yao; Xiao-Guang Li; Peng Wang; Xin Hu; Zhi-Ming Shao
Journal:  Theranostics       Date:  2020-08-21       Impact factor: 11.556

5.  A new signature based on alternative polyadenylation for prognostic prediction and therapeutic responses in low-grade glioma.

Authors:  Yuzhi Wang; Yunfei Xu; Yi Zhang
Journal:  Aging (Albany NY)       Date:  2022-01-18       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.